HRT Financial’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.48M Sell
46,745
-30,895
-40% -$842K 0.01% 1804
2025
Q4
$2.11M Buy
77,640
+13,471
+21% +$355K 0.01% 1268
2025
Q3
$1.66M Buy
64,169
+15,754
+33% +$365K 0.01% 1254
2025
Q2
$985K Buy
48,415
+26,997
+126% +$525K 0.01% 1277
2025
Q1
$388K Buy
+21,418
New +$479K ﹤0.01% 1628
2024
Q1
Sell
-13,243
Closed -$525K 2410
2023
Q4
$525K Sell
13,243
-8,362
-39% -$246K ﹤0.01% 1334
2023
Q3
$594K Buy
+21,605
New +$677K 0.01% 1308
2023
Q1
Sell
-69,796
Closed -$3.11M 2578
2022
Q4
$3.11M Buy
+69,796
New +$2.49M 0.05% 413
2022
Q1
Sell
-20,487
Closed -$791K 3206
2021
Q4
$791K Buy
+20,487
New +$893K ﹤0.01% 1322
2021
Q2
Sell
-110,306
Closed -$2.27M 2940
2021
Q1
$2.27M Buy
110,306
+9,387
+9% +$216K 0.03% 552
2020
Q4
$1.77M Buy
+100,919
New +$1.82M 0.04% 364
2019
Q1
Sell
-5,179
Closed -$15K 552
2018
Q4
$15K Buy
5,179
+3,953
+322% +$19.4K ﹤0.01% 558
2018
Q3
$8K Buy
1,226
+428
+54% +$3K ﹤0.01% 390
2018
Q2
$6K Buy
+798
New +$10.7K ﹤0.01% 262

Other funds holding CLDX